Market revenue in 2024 | USD 114.7 million |
Market revenue in 2030 | USD 302.3 million |
Growth rate | 17.5% (CAGR from 2024 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 37.84% in 2024. Horizon Databook has segmented the India oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Due to the high birth rate, India has a high prevalence of genetic disorders due to various factors, such as consanguineous marriages and founder mutations. Oligonucleotides are essential for prenatal screening, carrier testing, and genetic counseling for these disorders. They are also used for potential gene therapy applications.
Furthermore, initiatives like “Make in India” and grants for R&D empower domestic players and attract foreign investments, impacting the oligonucleotide market. For instance, in September 2019, the Department of Biotechnology (DBT) launched the Unique Methods of Management & Treatment of Inherited Disorders (UMMID) initiative in India to tackle inherited genetic diseases in newborn babies.
Horizon Databook provides a detailed overview of country-level data and insights on the India oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into India oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account